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Diuretics continue to be among
the commonest of all prescribed
items. Until recently, the physician
needed to have little concern about
the dose of the agent he was choosing because firstly, the dose-response curve tended to be startlingly flat, and secondly, there was
little chance of inducing an excessive diuresis, regardless of dose.
Now that furosemide (Lasix) and
ethacrynic acid (Edecrin) have become available, we find that one
must indeed titrate the dose to the
particular patient, and must appreciate for the first time the complications which can result from an
excessive diuresis. Finally, with the
availability of triamterene and MK870 ( Colectril, not yet available),
one must appreciate the importance of the distal tubular mechanism for potassium for sodium exchange. The additive effect of these
exchange inhibitors can be of considerable clinical usefulness .
Adverse Effects of Diuretics

Figure 1 illustrates the excessive
diuresis which can result from the
newer, more potent diuretics. This
R_atient was hospitalized and started
on what seemed like a reasonable
dose of ethacrynic acid, but she
lost 35 pounds in four days. Fortunately, this patient had no adverse effects, but this is the very
circumstance in which the series
of adverse effects shown in table 1
can occur. The most important of
these is hypovolemia. This is particularly likely to occur in the patient with cirrhosis or nephrosis.
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The problem is one of developing
circulatory collapse, shock. The
only treatment advisable then is
the infusion of salt-poor albumin.
Such episodes have been reported
with some real frequency. The
problem of inducing excessive potassium loss is primarily related to
the patient who is also taking digi talis and who becomes much
more susceptible to the ectopic activity of the cardiac glycosides. Hypochloremia will induce diuretic
refractoriness to mercurials, but
not to these new agents. In spite of
electrolyte derrangements and in
spite of reduction in renal blood
flow, furosemide and ethacrynic
acid will continue to exert diuretic
effects. Hyponatremia may develop,
particularly in the patient who is
having a marked saluresis and who
replaces the volume with tap water.
The cause of muscle cramps, the
weakness, the "washed-out" feeling, is still not clear, but the symptoms are well-recognized in patients in whom a marked prompt
diuresis ensues. The relationship to
thrombosis and the development of
gout are not clear, but there is
some circumstantial evidence suggesting that these can occur during
diuresis. In summary, one must
avoid having too rapid and too
massive a diuresis.
Table 2 suggests some measures
to avoid adverse effects of diuretics.
The most important is the first:
choose a sub-maximally effective
dose. This requires knowing something about the dose response to
these new agents. The only way to
judge the response, of course, is to
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TABLE 1
Results of Excessive Diuresis
1. Hypovolemia
a. Reduction in renal blood
flow
b. Circulatory collapse
2. Hypokalemia
a. Digitalis intoxication
3. Hypochloremia
a. Mercurial refractoriness
4. Hyponatremia
a. Water intoxication
5. Muscle cramps
6. Weakness
7. ? Thromboses
8. Acute gout
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TABLE 2
Routine Measures on Initiating a
Diuresis
1. Choose a submaximal diuretic
dose.
2. Record weights and fluid balance.
3. Restrict activity.
4. Reduce sodium intake.
5. Restrict fluids to 1 to 1.5 liters,
especially the day after diuresis.
6. Watch blood Na, K, Cl, HCOs,
urea and hematocrit.
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Fig. 1- An excessively rapid response to ethacrynic acid.

record weights and fluid balance.
Weights must be recorded by every
out-patient who is taking diuretics
for their diuretic properties. If a
poor response from the diuretic
occurs, restnctmg the patient's
physical activity during the day
will often enhance the diuresis,
since in heart failure, physical activity reduces renal blood fl.ow.
Fluids need be restricted only if
the patient appears to be one who
has the habit of ingesting water
followin g a marked diuresis. No
simple rule can be offered for the
frequency of determining serum
electrolytes. If the patient is having
a marked response, they should be
checked. Obviously, if he is hav-

ing a poor response, they should
be checked. With the new agents
which continue to be effective even
in the face of electrolyte abnormalities, it is necessary to check them
with some regularity, like once every week or two.

vantage with the exception of a
more prolonged activity. In this
sense it more closely resembles
chlorthalidone. It has no other advantages and no other disadvantages.
Furosemide

Quinethazone

The first new agent to consider
is quinethazone (Hydromox). Figure 2 shows the structural formula
for quinthazone. Note the similarity to chlorthalidone (Hydroton)
and to chlorothiazide (Diuril).
Quinethazone is thus another one
of the large group of thiazide derivatives. It has no particular ad-

The structural formula for furosemide (Lasix) is shown in figure 3.
Furosemide has also been called
fursemide and frusemide. This is
an agent whose activity-structure
relationship is still not clear. Some
would suggest that it is the common grouping with the thiazides;
others would suggest that it is the
free carboxyl group which is re83
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Fig. 2-Structural formulae of quinethazone (I;:lydromox), chlorthalidone
(Hygroton), and chlorothiazide (Diuril).
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Fig. 3-Furosemide (Lasix), 4-chloro-N-(2-furylmethyl)-5-sulfamoyl-anthranilic
acid.

sponsible for its diuretic activity.
It is clear that it is different from
the thiazides in several ways.
Firstly, it is active in an animal in
which there is no liver. The thiazides require the presence of the
liver before diuresis will ensue.
Secondly, furosemide causes a decrease in bicarbonate excretion in
contrast to the typical thiazides.
Thirdly, there is a markedly different order of efficacy. Furosemide clearly works in the ascending loop of Henle. It probably
works in the proximal tubule, although animal micropuncture studies give contrary evidence. It has
been said, though, and we have all
been taught, that some 80% of the
normal glomerular filtration is reabsorbed in the proximal tubule.
If a diuretic were 100% effective,
theoretically it could only increase
urine output to 20 % of the filtration rate if it had no activity in the
proximal tubule. Furosemide can
produce a diuresis of as much as
one-half of the glomerular filtration rate, and this has been used as
evidence that it must alter the
proximal tubular reabsorption of
salt and water.
Figure 4 shows the human response to furosemide contrasted
with hydrochlorothiazide at 50 to
75 mg of each. Note that furosemide produces a larger diuresis,
natriuresis and chloruresis, but importantly, no greater kaluresis. For
each milliequivalent of sodium excreted, furosemide causes less potassium excretion than do the thiazides.
Furosemide is very rapidly effective, acting in minutes when
given intravenously. Its maximum
effect occurs within two hours when
given orally. The duration of effect
is correspondingly short. The dose
response curve is shown in figure
5. In the case of hydrochlorothiazide, increasing the dose from 50
to 100 mg causes only a modestly
increased natriuresis, whereas increasing the dose of furosemide
from 50 to 100 mg causes a very
considerable difference. Furose-
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mide, therefore, differs in potency,
that is, more diuresis per milligram,
but more importantly, it differs in
efficacy, giving a maximum response beyond what can be achieved with any of the thiazides.
The toxicity of furosemide is
still under investigation. Table 3
lists the toxic reactions. Rare hypersensitivities, usually rashes and
rare, not definitely causally-related
alteration in blood counts have
been reported. N ausea and vomiting appear to be clearly dose-related and will occur quite frequently at single doses exceeding
200 mg. Furosemide causes hyperuricemia regularly and will precipitate acute gout occasionally. Pancreatitis and hyperglycemia have
now been reported in association
with furosemide therapy, but are
not yet established clearly as causally related. The extent of the
hyperglycemia appears to be considerably less than .that which occurs with the benzothiadiazines.
The major problem with furosemide is excessive diuretic effect.
This is the major adverse effect in
the use of this agent.
In summary, then, furosemide is
some three to five times as efficacious as the thiazides and causes
less potassium loss. Because it is so
rapidly effective, it has been used
in the treatment of pulmonary
edema and in cerebral edema. It is
important to note that it has a
steep dose response curve and that
it continues to be effective even in
the face of electrolyte derrangement, hypovolemia, and azotemia.
Ethacrynic Acid

The structural formula for ethacrynic acid (Edecrin) is shown in
figure 6. Note here the absence of
the sulfamyl group, but again the
hallogenated cyclic structure. The
free carboxyl group is thought to
be a major determinant of its activity. This agent appears to work
on the identical tubular mechanisms affected by furosemide. If one
gives a maximally effective dose, of
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either furosemide or ethacrynic
acid, and then gives the other agent,
no further response ensues. This
would tend to indicate that the
same mechanisms are affected by
the two agents. Figure 7 shows the
pattern of electrolyte excretion; a
marked chloruresis, natriuresis, diuresis, and a minimal kaluresis.
This is similar to the pattern shown
for furosemide (fig. 4). When
ethacrynic acid is given intravenously, an extremely prompt and
massive response can be expected.
Ethacrynic acid is available for parenteral use and is recommended
in the treatment of pulmonary

a very steep dose response relationship. One patient whom we treated
in the metabolic ward is shown in
figure 9. Note that with gradually
increasing doses from 50 to 100
mg, there was essentially no response in weight. With an increase
to 150 mg, there ensued a slow but
steady diuresis until dry weight was
obtained. This was a patient known,
from our previous experience with
her, to have highly resistant congestive heart failure.
Table 4 indicates the toxicity,
which is probably identical to what
was listed for furosemide. Rare
rashes and thrombocytopenia have

edema. A diuresis of 500 or 600
ml in one hour is not unusual. This
is equivalent to using a phlebotomy
or venous tourniquets to reduce the
circulating blood volume. Figure 8
illustrates the response of one such
patient. One and one-half liters of
urine had been passed in one hour
after 50 mg of intravenous ethacrynic acid, and about 3 liters by
three hours.
The dose response curve is also
shown in figure 7. There is an increasing response until one reaches
a dose of 200 mg, and at that point
maximal therapeutic effect has
been achieved . So again, there is

Cl

TABLE 3

Cl

Toxic Effects of Furosemide
1. Rare hypersensitivity
2. Nausea, vomiting (dose related)
3. Hyperuricemia and gout
4. Pancreatitis
5. Hyperglycemia
6. Excessive effect
Hypovolemia; hypochloremic
alkalosis; hypokalemia; hyponatremia
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Fig. 6-Ethacrynic acid (Edecrin), 2, 3-dichloro-4-(2-methylenebutyryl) phe·
noxyacetic acid.
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TABLE 4
Toxic Effects of Ethacrynic Acid
1. Rare hypersensitivity

2. Nausea, vomiting, diarrhea
(dose related)
3. Hyperuricemia and gout
4. Tinnitus, vertigo, deafness
5. Excessive effect
Hypovolemia; hypochloremic
alkalosis; hypokalemia; hyponatremia
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4. Hyperkalemia

150

l&J ~

~>

p···

...··.. a···· ····a No+

I

6

//
.

.

z

olTl

<

)>

~

z

!Tl~

/-_,,URINE

2000

rC1l

VOL.

)>

:c

~ .~

1500

,.1

I
11
11
II
11
I I

£

2500

0

:v
,a'/i ·D /
·11/

o0:: E

t; g

./

1' ....
/6 /

~ ~200
~~

CJ) l&J

Toxic Effects of Triamterene

I

250

u

l&J

TABLE 5

3000

z

ID C
0 :0

g~
1000 ;;;~

:c r

.::..c

!!::

500

ITl

U>

0

Fig. 7-Urinary response to graded doses of ethacrynic acid (Reproduced with
permission of Merck, Sharp & Qohme Research Laboratories).
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been reported; nausea, vomiting,
and diarrhea appear to be doserelated. Hyperuricemia and gout
will occur. Tinnitus, vertigo, and
deafness have been reported with
ethacrynic acid. It would appear to
be a function of the acute change
of the dynamics across the inner
ear endolymph, since continued
therapy with the agent is not associated with continuing or worsening of these symptoms, but
rather they tend to disappear over
a few days as soon as fluid balance
appears to be more stable. This is
probably not toxicity in the usual
sense any more than excessive effect is toxicity, but is an extension
of the phamacologic properties of
these rapidly and potently active
diuretic agents. Excessive effect was
considered earlier.
Ethacrynic acid, then, is also a
potent, highly-effective diuretic. It
continues to be active in the face
of electrolyte derrangements and
azotemia. It is available for intravenous use and probably has a
real place in the treatment of the.
patient with acute pulmonary
edema in addition to our usual
measures.
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Fig. 8-Urine volume (cumulative) following intravenous administration of
ethacrynic acid in a patient with acute pulmonary edema occurring in the course
of chronic congestive heart failure.

Triamterene and Amiloride

Turning now to agents that act
by entirely different mechanisms,
triamterene (Dyrenium), now
available, and amipramizide or
amiloride (Cholectril) (MK-870) ,
not yet available, are shown in
figure 10. The similarity in the
structures is evident. There is a
considerable difference in the potency as triamterene is given in
doses of 100 to 200 mg and amiloride is given in doses of 5 to 30
mg. These are the agents which act
to block the sodium-potassium exchange mechanism in the distal
tubule. This is totally different
from any of the activities of the
other two agents described above.
They are similar in effect to spironolactone, but spironolactone is a
competitive inhibitor of aldosterone
and is thus only effective in the
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Fig. 9-Response to graded doses of ethacrynic acid in a patient with diureticresistant chronic congestive heart failure.
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presence of aldosterone. These
agents block this tubular reabsorptive mechanism regardless of whether aldosterone is present. In this
way they tend to be more effective
and do not require that the patient
be in a state of induced hyperaldosteronism.
One can then predict the diuretic
response. Figure 11 depicts a modest increase in sodium excretion
and a decrease in potassium excretion in response to triamterene. Essentially a maximal effect results
from a dose of about 100 mg of
triamterene. These agents are modest in their naturetic effect.
Something of the toxicity is
noted in table 5. Again rare hypersensitivity and dose related nausea
and vomiting are listed. Azotemia
has been interesting in that slight,
but significant increases in blood
urea nitrogen have been recorded.
They tend to stabilize and have not
generally been a cause of significant concern. The problem with
these agents is the development of
hyperkalemia. When given either
alone or in conjunction with thiazides, triamterene and amiloride
may cause serious and even fatal
hyperpotassemia. There is no way
to predict in a given patient the
exact response. Potassium levels
must be checked in patients receiving such therapy.
In summary, these two agents,
triamterene and amiloride have a
modest natriuretic effect, about onehalf to one-fourth that of the thiazides. They cause potassium retention, and most importantly, they
are additive in effect to the other
diuretics, thiazides, furosemide, and
ethacrynic acid. Figure 12 illustrates this additive effect. This is
the same resistant patient (fig. 9)
treated on an out-patient basis receiving furosemide. Note that 40,
80, 160, and even 240 mg of furosemide per day was associated
with no significant weight loss. At
this point triamterene was added to
this steady regimen, and the patient achieved a weight loss of approximately a pound per day over
88
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the next two weeks. These agents
have not been shown to induce hyperglycemia or hyperuricemia and
may have some special advantage
in patients in whom these are problems.
Some of the typical effects of
differing types of diuretic agents
can be noted in the results of a
study we have done.* Twelve patients with chronic congestive heart
failure, hospitalized on our metabolic ward on constant sodium and
fluid intake, were each given ethacrynic acid, triamterene and hydrochlorothiazide. Each patient received all three drugs, one on each
of three successive days. The order
of administration was so randomized that each drug was given with
equal frequency on the first, second, and third days. 100 mg of
each diuretic was given at 8 AM
and again at noon. Carry-over effect was minimized since 20 hours
separated the successive drugs.
Statistical analysis indicated no
significant variation due to the order of drug administration or to
the pattern of individual patient response. There were, however, statistically significant differences in
the responses to the three diuretics.
Ethacrynic acid effected a significantly greater weight loss, natriuresis, chloruresis, and diuresis
than did hydrochlorothiazide or
triamterene and did so in both the
first four hours and for the 24
hour period (fig. 13). Hydrochlorothiazide resulted in a somewhat
greater diuresis, natriuresis, and
chloruresis than did triamterene,
but these differences were not statistically significant at the 5 % level
of probability.
On the other hand, triamterene
resulted in significantly less kaluresis than either ethacrynic acid or
hydrochlorothiazide. The potassium
excretion with the latter two was
not significantly different.
This study, then, substantiates
the greater potency (diuresis, salu-
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Fig. 12- The additive effect of triamterene and furosemide in a patient with
diuretic-resistant chronic congestive heart failure.

* Proctor, J. D ., and A. J. Wasserman, to be published.
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resis) of ethacrynic acid and the
potassium sparing effect of triamterene. In this study, furthermore,
ethacrynic acid effected the most
favorable sodium-to-potassium excretion ratio, viz for each milliequivalent of potassium lost, etha·crynic acid caused the greatest loss
of sodium (fig. 14). Stated conversely, less potassium was lost for
each milliequivalent of sodium excreted with ethacrynic acid than
with either hydrochlorothiazide or
triamterene.

Summary

There are now a number of different classes of diuretics with different pharmacologic effects. Sev-
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era! considerations dictate the
choice of diuretic:
1. The responsiveness of the patient is of prime importance. If
the patient is not known to be resistant to diuretic therapy, thiazides
should be tried first.
2. The danger of alterations of
volume and of electrolytes in the
specific patient must be considered .
Patients receiving digitalis will be
subjected to much greater danger
by the induction of hypokalemia
than patients not receiving cardiac
glycosides.
3. The pharmacologic effects of
the specific diuretics must be understood for now the physician
has available agents of differing
potency, efficacy, and especially
differing mechanisms of action.
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